Inventor · disambiguated record
Anita Liberman
Also filed as: LIBERMAN ANITA
20 granted patents·20 pending applications·137 citations·filing 1999–2009
94Inventor score
Top patents by PatentIndex Score
40 records- 0197US6495721B1Sertraline hydrochloride Form II and methods for the preparation thereofTEVA PHARMA·Filed 2000·Granted Dec 17, 2002·58 cites·22 claims
- 0285US7060837B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Jun 13, 2006·3 cites·16 claims
- 0384US6600073B1Methods for preparation of sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2000·Granted Jul 29, 2003·14 cites·29 claims
- 0484US6500987B1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 1999·Granted Dec 31, 2002·38 cites·89 claims
- 0582US7022859B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Apr 4, 2006·2 cites·15 claims
- 0676US7534900B2Process for the purification of duloxetine hydrochlorideTEVA PHARMA·Filed 2006·Granted May 19, 2009·3 cites·8 claims
- 0776US6909004B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2003·Granted Jun 21, 2005·5 cites·1 claims
- 0874US7399871B2Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereofTEVA PHARMA·Filed 2006·Granted Jul 15, 2008·1 cites·15 claims
- 0972US7022881B2Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2004·Granted Apr 4, 2006·3 cites·6 claims
- 1070US6723855B2Method for synthesizing leflunomideTEVA PHARMA·Filed 2001·Granted Apr 20, 2004·4 cites·26 claims
- 1170US6545149B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2001·Granted Apr 8, 2003·3 cites·24 claims
- 1268US6576764B2Synthesis and crystallization of piperazine ring-containing compoundsTEVA PHARMA·Filed 2002·Granted Jun 10, 2003·2 cites·5 claims
- 1366US2008287550A1Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 1466US2010029943A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneTEVA PHARMA·Filed 2009·Application pending·0 cites
- 1565US2008176949A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2008·Application pending·0 cites
- 1662US7842717B2DNT-maleate and methods of preparation thereofTEVA PHARMA·Filed 2006·Granted Nov 30, 2010·0 cites·15 claims
- 1762US7196222B2Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2004·Granted Mar 27, 2007·1 cites·6 claims
- 1861US7319171B2Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2006·Granted Jan 15, 2008·0 cites·16 claims
- 1961US2009012316A1Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-Napathalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2060US2007093557A1Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2160US2006241189A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2259US7622588B2Method for the purification of lansoprazoleTEVA PHARMA·Filed 2005·Granted Nov 24, 2009·0 cites·3 claims
- 2359US2007270590A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneMENDELOVICI MARIOARA·Filed 2007·Application pending·0 cites
- 2459US2008027223A1Polymorphs of eszopiclone malateTEVA PHARMA·Filed 2007·Application pending·0 cites
- 2557US2008004319A1Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleBRAUDE VIVIANA·Filed 2007·Application pending·0 cites
- 2656US7683177B2Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazoleTEVA PHARMA·Filed 2004·Granted Mar 23, 2010·0 cites·8 claims
- 2754US2003055112A1Sertraline hydrochloride polymorphsFiled 2002·Application pending·0 cites
- 2854US2002183555A1Sertraline hydrochloride form II and methods for the preparation thereofFiled 2002·Application pending·0 cites
- 2951US7678816B2Method of stabilizing lansoprazoleTEVA PHARMA·Filed 2004·Granted Mar 16, 2010·0 cites·8 claims
- 3050US7683080B2Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcoholTEVA PHARMA·Filed 2003·Granted Mar 23, 2010·0 cites·18 claims
- 3150US2004176591A1Novel synthesis and crystallization of peperazine ring-containing compoundsFiled 2004·Application pending·0 cites
- 3250US2003120068A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2003·Application pending·0 cites
- 3350US2007191471A1DNT-fumarate and methods of preparation thereofINI SANTIAGO·Filed 2006·Application pending·0 cites
- 3450US2004127532A1Method for synthesizing leflunomideFiled 2003·Application pending·0 cites
- 3549US2003135043A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2003·Application pending·0 cites
- 3645US7759500B22-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochlorideTEVA PHARMA·Filed 2006·Granted Jul 20, 2010·0 cites·25 claims
- 3741US2006194869A1Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereofINI SANTIAGO·Filed 2005·Application pending·0 cites
- 3840US2003069417A1Novel synthesis and crystallization of piperazine ring-containing compoundsFiled 2002·Application pending·0 cites
- 3938US2006128788A1Purification of tegaserod maleateINI SANTIAGO·Filed 2005·Application pending·0 cites
- 4033US2006106086A1Preparation of tegaserod and tegaserod maleateINI SANTIAGO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anita Liberman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →